Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis

Neurology
Alvaro AlonsoMiguel A Hernán

Abstract

It is unclear whether allergic diseases are associated with multiple sclerosis (MS), but histamine 1 receptor blockers, used in the treatment of allergic conditions, decreased the severity of experimental autoimmune encephalomyelitis (an animal model of MS). To assess the association of allergy history and use of histamine 1 receptor blockers with the risk of MS. Using a case-control study nested in the United Kingdom-based General Practice Research Database cohort, the authors identified 163 incident cases of MS with at least 3 years of follow-up before their first symptoms (index date). Up to 10 controls matched to the cases by age, sex, general practice, and time in the cohort were selected. Previous history of allergic disease and use of histamine 1 receptor blockers in the 3 years before the index date were assessed through computerized medical records. History of any allergic condition in the 3 years before the index date was not associated with MS risk (adjusted odds ratio [OR] 1.2, 95% CI 0.8 to 1.8). However, use of sedating histamine 1 receptor blockers was associated with decreased MS risk (adjusted OR 0.2, 95% CI 0.1 to 0.8). These results do not support a strong link between allergic conditions and multiple scleros...Continue Reading

Citations

Oct 20, 2010·Proceedings of the National Academy of Sciences of the United States of America·Changming LuCory Teuscher
Jan 30, 2008·The Journal of Experimental Medicine·Walid BeghdadiSalaheddine Mécheri
Jun 23, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·E García-MartínF J Jiménez-Jiménez
Oct 30, 2007·The Journal of Clinical Investigation·Rajkumar NoubadeCory Teuscher
Jun 6, 2007·Proceedings of the National Academy of Sciences of the United States of America·Cory TeuscherElizabeth P Blankenhorn
Aug 2, 2014·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Behnam MansouriAfshin Divani
May 10, 2011·FEBS Letters·Catherine LarochelleAlexandre Prat
May 25, 2010·Neuropharmacology·Farhad Jadidi-Niaragh, Abbas Mirshafiey
May 29, 2008·Clinical and Experimental Immunology·R L Rabin, A I Levinson
Dec 22, 2007·Acta Neurologica Scandinavica·A AlonsoA Ascherio
May 12, 2007·Annals of Neurology·Alberto Ascherio, Kassandra L Munger
May 12, 2010·Acta Neurologica Scandinavica·L MonteiroA Melo
Dec 17, 2015·Annual Review of Public Health·Joan A CaseyNancy E Adler
Jun 13, 2015·Journal of Neurology·Susan S JickM-A Wallander
May 20, 2014·Journal of Neurology·S S JickM-A Wallander
Jan 3, 2014·Clinical & Developmental Immunology·Nathalie DeckxNathalie Cools
Jun 24, 2015·Nature Reviews. Neurology·Ling ShanJerome M Siegel
May 13, 2014·Frontiers in Cellular Neuroscience·Sandra M RochaLiliana Bernardino
Oct 19, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Fang WangGuoping Peng
Apr 16, 2014·Multiple Sclerosis : Clinical and Laboratory Research·Ching-Piao TsaiCharles Tzu-Chi Lee
Apr 30, 2017·Current Medical Research and Opinion·Jinma RenCarl V Asche
Jun 10, 2017·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Ippazio Cosimo AntonazzoElisabetta Poluzzi
Aug 12, 2009·Multiple Sclerosis : Clinical and Laboratory Research·R PedottiG Filippini
Jun 21, 2013·Nature Reviews. Neuroscience·Pertti Panula, Saara Nuutinen
Jul 16, 2008·Physiological Reviews·Helmut L HaasOliver Selbach
Jun 19, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Naresha SaligramaCory Teuscher
Dec 7, 2017·Pharmacoepidemiology and Drug Safety·Heather Y YongHelen Tremlett
Mar 24, 2020·Expert Review of Neurotherapeutics·Fardowsa L A YusufHelen Tremlett
Dec 8, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Roxana del RioCory Teuscher
Apr 14, 2021·The Journal of Immunology : Official Journal of the American Association of Immunologists·Françoise MorinLuc Vallières
Jun 18, 2021·Journal of the Neurological Sciences·Paola Di MauroDavide Domenico Borzì

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.